1. An update on the latest strategies in retinal drug delivery
- Author
-
Ranch, Ketan, Chawnani, Disha, Jani, Harshilkumar, Acharya, Devarshi, Patel, Chirag Amrutlal, Jacob, Shery, Babu, R. Jayachandra, Tiwari, Amit K., Al-Tabakha, Moawia M., and Boddu, Sai H. S.
- Abstract
ABSTRACTIntroductionRetinal drug delivery has witnessed significant advancements in recent years, mainly driven by the prevalence of retinal diseases and the need for more efficient and patient-friendly treatment strategies.Areas coveredAdvancements in nanotechnology have introduced novel drug delivery platforms to improve bioavailability and provide controlled/targeted delivery to specific retinal layers. This review highlights various treatment options for retinal diseases. Additionally, diverse strategies aimed at enhancing delivery of small molecules and antibodies to the posterior segment such as implants, polymeric nanoparticles, liposomes, niosomes, microneedles, iontophoresis and mixed micelles were emphasized. A comprehensive overview of the special technologies currently under clinical trials or already in the clinic was provided.Expert opinionIdeally, drug delivery system for treating retinal diseases should be less invasive in nature and exhibit sustained release up to several months. Though topical administration in the form of eye drops offers better patient compliance, its clinical utility is limited by nature of the drug. There is a wide range of delivery platforms available, however, it is not easy to modify any single platform to accommodate all types of drugs. Coordinated efforts between ophthalmologists and drug delivery scientists are necessary while developing therapeutic compounds, right from their inception.
- Published
- 2024
- Full Text
- View/download PDF